Old Web
English
Sign In
Acemap
>
authorDetail
>
Héctor Santana
Héctor Santana
Biotec
Peptide
Internal medicine
NF-κB
Stable Disease
Oncology
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Formulation matters! A spectroscopic and molecular dynamics investigation on the peptide CIGB552 as itself and in its therapeutical formulation.
2021
Journal of Peptide Science
Marco Savioli
Lorenzo Antonelli
Gianfranco Bocchinfuso
Francesca Cavalieri
Rita Cimino
Emanuela Gatto
Ernesto Placidi
Julio Raul Fernandez Masso
Hilda Elisa Garay Perez
Héctor Santana
Maribel Guerra-Vallespi
Mariano Venanzi
Show All
Source
Cite
Save
Citations (1)
A first-in-class, first-in-human, phase I trial of CIGB-552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF-κB in patients with advanced solid tumors.
2021
International Journal of Cancer
Maribel G. Vallespi
Braulio Mestre
María A Marrero
Rolando Uranga
Diana Rey
Martha Lugiollo
Mircea Betancourt
Kirenia Silva
Danay Corrales
Yanet Lamadrid
Yamilka Rodriguez
Anaelys Maceo
Pedro P Chaviano
Gilda Lemos
Ania Cabrales
Freya Freyre
Héctor Santana
Hilda Garay
Brizaida Oliva
Julio R. Fernández
Show All
Source
Cite
Save
Citations (0)
1